Dummy news
Test
Read More
News and Media
Latest news
Inspiring Inclusion: Celebrating International Women's Day at Accord
As we mark International Women's Day, we are reminded of the profound influence women have in every sphere of our lives. At Accord Healthcare, we take this moment not only to celebrate the incredible women among us but also to introspect and strive towards a more inclusive future. In a thought-provoking piece by our Senior Vice President HR, Lis Allen, we're invited to reflect on the essence of this year's theme: 'inspire inclusion'. It's a call for women to make empowered career choices, a call to support women through all life stages, and a call to recognise the unique challenges women may face. Read the story here: https://www.linkedin.com/</wbr>pulse/inspiring-inclusivity-</wbr>showing-way-others-accord-</wbr>healthcare-m3jke/?trackingId=</wbr>wmIBp0jcSSGt%2FNeNoPB07A%3D%3D
Read MoreAccord Healthcare nominated for 'Pf 2024' award
Once more, Accord Healthcare earns a spot among the finalists at the prestigious Pf Awards. This time in the Patient Impact category. This nomination recognises our unwavering dedication to the Medicines Repurposing Programme, in collaboration with NHS England. It's a moment that underscores our commitment to pioneering new pathways in healthcare and increasing access to vital medicines for patients. We are grateful to be shortlisted amongst an impressive array of entries. This nomination reflects our collective ambition to elevate healthcare standards, with a keen focus on enhancing quality, safety, and broadening treatment options in partnership with entities like the MHRA and NHS England. Hats off to our Regulatory teams for their remarkable dedication and pursuit of excellence. Their pivotal contributions have been instrumental in achieving this notable recognition.
Read MoreWorld Cancer Day 2024: Accord committed to helping close the gap in cancer care
The stark reality today is that despite huge advances, one in two of us will develop some form of cancer in our lifetime. This poses a huge challenge in developing treatments that can save lives and improve quality of life. As Accord continues to work to develop therapies for cancer and other life-threatening diseases, we are also striving to ensure our innovative treatments are accessible to those that need it most. In observance of World Cancer Day this year Accord is delighted to partner with ITN Business in a programme to demonstrate the many ways patient groups, research organisations, government and industry are dedicated to Shaping the Future of Cancer Care together. By marking this important day and sharing what we stand for we are demonstrating our commitment to helping fight this disease and really make it better for patients in as many ways as possible. Watch the film below.
Read MoreAccord wins four ‘Pharmaceutical Technology Excellence’ awards
What a wonderful way to end the year! Accord Healthcare is a Category Award Winner in four areas in the 2023 Pharmaceutical-Technology Excellence Awards – Business Expansion, Product Launches, Research and Development, and Social Impact. These accolades are a testament to our unwavering dedication and innovative approach across the categories. Research and Development: Our commitment to groundbreaking research in biologics has led to the establishment of a new, advanced laboratory in London, further strengthening our research and development capabilities. Product Launches: This year, we've continued our focus on the oncology sector. While adhering to the highest standards of compliance and ethical practice, we've made strides in providing supportive care and options in this crucial area of medicine. Business Expansion: Accord’s Business Development team has significantly enhanced our market presence through strategic partnerships and resource optimisation. Our strategy has been instrumental in expanding access to vital medicines across Europe, with an ambitious roadmap for launching new products that will continue to enhance patient care. Social Impact: Our combined efforts in 'Project Hope' and other initiatives have made a significant impact, providing essential medical assistance and humanitarian aid, notably in Ukraine, demonstrating our commitment to global health and social responsibility. We're immensely proud of these recognitions and remain dedicated to enhancing health and making it better around the world. #makeitbetter
Read MoreAccord in 2023: Watch our End of Year video
As the year draws to a close, I want to express my immense gratitude to our incredible team at Accord Healthcare. Their dedication, commitment and hard work have been pivotal in navigating this challenging yet rewarding year. 2023 was a year of significant milestones for us: Launching our first major novel product, a testament to our innovation and commitment to healthcare. Signing a significant license deal in oncology, demonstrating our dedication to advancing cancer care. Collaborating with NHS England's Medicines Repurposing Programme, contributing to important healthcare advancements. These achievements, driven by our three-pillar strategy, showcase our commitment to innovation, patient care, and thinking differently. Our growing corporate reputation is a testament to our team's efforts, underscored by our success at major industry awards and our continued recognition at the Global Generic Bulletin awards. This year also saw us expand our teams across Accord, with new talents bolstering our leadership and teams, especially in Manufacturing and Commercial. Our focus on fair, kind policies and compassionate leadership has been positively reflected in our annual People survey. As we stand at the cusp of 2024, I'm thrilled to see us united as ‘One Accord.’ The strides we've made together are just the beginning of our journey. A big thank you to every team member for making Accord better! To celebrate, we've put together a film highlighting this year's achievements. We hope you enjoy sharing our fantastic year with us. Here's to making 2024 better for patients, healthcare professionals and our communities! Paul Treadwell Executive Vice President Accord Healthcare </source>
Read MoreAccord Healthcare wins ‘CSR World Leader 2023’ award
We are delighted to announce that Accord Healthcare has been recognised as a CSR World Leader at the International Green Apple Awards, held at the Houses of Parliament in Westminster and hosted by The Green Organisation. This esteemed accolade acknowledges our unwavering commitment to corporate social responsibility (CSR) and shines a light on our collaboration with International Health Partners. Together, we've made strides in securing access to vital medicines for some of the most vulnerable populations around the globe. We have consistently demonstrated leadership in embracing sustainable practices, cultivating a diverse and inclusive workplace, and actively engaging in social initiatives. Our approach to CSR is deeply ingrained in our company culture, driving us to operate responsibly and contribute to a more equitable and sustainable future. This award speaks volumes of our entire team's hard work and dedication. It is also a reflection of the strength and support of our continuing partnership with IHP and the communities we both serve. We are honoured to stand among other organisations that share our passion for making a positive difference in the world. To all who have been part of our journey—thank you. We couldn't have done it without you. Together, we make it better.
Read MoreAccord Healthcare launches Accord Animal Health
Accord Healthcare, one of the fastest-growing pharmaceutical companies in Europe, committed to providing high-quality medicines at the point of care, is launching an Animal Health division to ‘make it better’ for Vets. Recent years have created a ‘perfect storm’ of pressure on veterinary services. There are now 34 million pets in the United Kingdom (UK), over 10% of which were acquired during the COVID-19 Pandemic1 . But with the cost-of-living biting pet owners, vets are being squeezed by increasing numbers of pet owners who can’t afford their bills coupled with price increases from suppliers. Many vets now feel that there is a large gap between what they need from their suppliers to support them and what they actually receive2 . We are setting up a new veterinary pharmaceutical division at Accord that firmly puts vets at the heart of everything we do.” Said Bob Ferguson who joined Accord in June 2022 from Norbrook Laboratories, a leading veterinary pharmaceutical company where he held several global senior roles for over 10 years. We will be listening to vet's concerns to understand their frustrations, ensuring that we supply products where they need them, when they want them, at the appropriate quality, and volume. We want to support vets and vet practices by cutting through. complexity, simplifying formulations, administration, and supply to make it better for vets.” – Bob Ferguson, Commercial Lead, Accord Animal Health “We are very excited to bring our extensive experience in pharmaceutical development, manufacture and commercialisation to Animal Health,” said Paul Tredwell, Executive Vice President of Accord EMENA “We are thrilled to launch our new division, where, we have extensive plans for growth and I look forward to working with Bob to grow his team and business, supporting Animal health and the Vets that are so critical to animal wellbeing.” Quality Medicines for Animal Healthcare | Accord Animal Health | Animal healthcare References: 1 UK Pet Food. New Pet Population Data Released. March 2021. Available at: https://www.ukpetfood.org/resource/pfma-releases-latest-pet-population-data.html. 2 Cost of Living Report CM Research January 2023
Read MoreAccord Supporting World Menopause Day 2023
45% of women feel their menopause symptoms have a negative impact on their work, with many exiting the workforce every year. Accord Healthcare is at the forefront of creating an environment and culture for people to be well at work with a wellbeing programme that empowers colleagues to take more direct control over their physical health. Find out more in our programme ‘Menopause: Misinformation and Management’, made in partnership with ITNBusinessUK. https://business.itn.co.uk/programmes/menopause-misinformation-and-management/ https://vimeo.com/872946545/ae95124dd8?share=copy
Read MoreSupporting IHP
Accord is pleased to be a supporter of IHP, funding programmes including; their child oncology programme with World Child Cancer supporting over 300 children at the Paediatric Oncology Unit, IHP's partner, World Child Cancer has been supporting children with cancer in Malawi since 2009 delivering training to bring local, regional and international experts together to share skills. In Malawi, the high cost of public transport has made access to hospitals challenging, and the increased costs of food and general living expenses on top of treatment-related costs have placed further strain on the families of children with cancer. The Paediatric Oncology Unit at Queen Elizabeth Central Hospital remains the only referral centre for all childhood cancer cases in Southern and Eastern Malawi. The POU also receives cases from districts in the central and northern parts of Malawi as well as bordering districts of Mozambique IHP has used our donations to support over 300 children at the Paediatric Oncology Unit, particularly those with Acute lymphoblastic leukaemia and germ cell tumours. Hope Nyondo’s mother, Cynthia, is a single parent of four. Her child’s diagnosis not only dealt a blow to Cynthia emotionally, but financially too. Hope was referred to the Queen Elizabeth Central Hospital where he was found to have cancer which is now being treated. I am happy that my child is improving compared to how he was when we just came in. I pray that those who have been helping with medicines should continue so that others like me can continue getting the much need assistance which we can’t afford because of the associated cost.” IHP's work to provide donated medicine free at the point of use to patients, is critical in ensuring that children can access the medicine they need and removes some of the agonising burden on families of children with cancer.
Read MoreEuropean-wide legal guidance on medicines procurement
To improve access to medicines, we need European-wide legal guidance on #medicines #procurement covering security of supply, MEAT criteria and biosimilar competition. With the #EUPharmaStrategy legislative reform, we along with Medicines for Europe hope to see the creation of more sustainable procurement awarding multiple winners and using additional criteria other than price.
Read MorePressures on the pharmaceutical industry with The Generics Bulletin
Accord’s Paul Tredwell, EVP EMENA discusses pressures on the pharmaceutical industry with The Generics Bulletin’s Dave Wallace. #inflation #pharmaceuticals #medicines https://generics.pharmaintelligence.informa.com/GB152642/Accord-EMENA-Chief-Says-Industry-Is-Pushing-Back-On-Pressures
Read MoreAccord Healthcare – The Guardian Future of Healthcare - Q1 2023
Accord Healthcare is committed to using digital technology to help empower patients with knowledge and understanding of their condition. In today’s The Guardian, Xavier Mesrobian highlights how we have collaborated with Macmillan Cancer and the Royal Marsden on the Unify Health app to better equip patients in their cancer care journey. Xavier Mesrobian highlights how the evolution of the patient information leaflet (PIL) via a digital makeover can provide the patient with at a glance information, that can be easily updated and supports the environment. Click to view the full article
Read MoreAccord Womens Network
We are delighted to launch the Accord’s Women’s Network (AWN). This is a growing group of colleagues united in a shared and common goal, to support women to thrive here at Accord Healthcare. Underpinning this aspiration with the following three pillars To Connect To Inspire To Empower To Connect Establishing a safe space to enable women across the entirety of our organisation to connect, to share experiences and collaborate in support of our organisational ambition. To Inspire To lead our industry sector as a compelling place for young women to come to work and thrive. Traditionally, science and engineering are areas that have been less accessible to women, we want to change this and be the employer to attract women apprentices and graduates. When women begin their careers, we want them to have access to ideas, guidance and mentoring using ‘Lean in’ circles and our own Mentoring platform. To Empower Supporting our colleagues to make choices and informed decisions about their career, engaging and educating our managers and leaders to develop their own compassionate leadership skills through empathy and understanding. We will create meaningful ways for women in Accord to grow and develop their own careers, breaking down any barriers and supporting them to flourish both in their work and personal lives. Through mentorship, learning resources and external subject matter experts we will create meaningful pathways for all with a laser focus on shaping the careers of future talent. AWN is open to all those who support the pillars and initiatives, regardless of gender, identity, or sexual orientation. Accord is proud to be an equal opportunities employer
Read MoreAccord Healthcare marks World Cancer Day 2023
As part of our commitment to advances in Oncology and the treatment of cancer, Accord is delighted to be involved in the programme 'Working Together: To Tackle Cancer', produced by ITN Business, anchored by UK based television presenter Simon Thomas. The programme showcases the scientific advances in treatment, raises awareness of subjects concerning people living with cancer and highlights how early diagnosis and a collaborative approach are key to a better future for patient outcomes. The full programme is now available to watch online at workingtogether.itn.co.uk. #CancerWorkingTogether #ITNBusiness #WorldCancerDay #Cancer
Read MoreAccord's approach to reducing environmental impact
The pharmaceutical sector is coming under increased scrutiny as the world wrestles with climate change and intensifies its demands on industries heavy on carbon emissions. Accord's Sustainable Sourcing Lead, Jane Wood, spoke to EMJ Gold publications about Accord's approach to reducing environmental impact across a complex and volatile supply chain. Jane outlined how suppliers must follow a strict code of conduct that encourages sustainable initiatives like swapping ait cargo for road or sea freight, consolidating orders and reducing packaging waste, This focus on sustainability can benefit both the environment and the business by creating cost savings, decreasing their carbon footprint, and ultimately creating a more ethical product. Read the full article here https://bit.ly/3PlRWI1 </source>
Read MoreAccord and IHP at Christmas
We're thrilled to announce that instead of giving Christmas cards this year Accord Healthcare has donated £3,500 to @ihp_uk! This amazing donation was doubled by #TheBigGive, making a total of £7,000 for our friends at IHP </source>
Read MoreWe are delighted to be named winners at the Global Generics & Biosimilars 2022 Awards in Frankfurt.
Paul Tredwell, EVP, EMENA says: “Year after year we are continuously recognised at these prestigious awards and that a is testament to our people, our culture and our drive to make it better and the innovations we invest in. “To be named Company of the Year, take the award for Biosimilar Initiative of the Year, Value Added Medicine Initiative of the Year, and Regulatory Achievement of the Year is a real accomplishment for everyone here at Accord and a real achievement to be awarded four in a highly competitive ceremony.”
Read MoreThank you to everyone who attended CPHI2022
Thank you to everyone who attended #CPHI2022 in Frankfurt and visited our exhibition stand. This year, as part of Corporate Responsibility goals and objectives Accord with Intas and other partners, donated £20,000 to our corporate charity partner @IHP over providing ‘giveaways’ at our exhibition stand. This initiative has not only supported IHP to further provide access to medications to war-torn and disaster struck countries but has also contributed to our sustainability commitments to reduce the need for single use plastic and other items. #CSR #CharitableGiving #CPHI2022 #Sustainability #Recycling #MakeitBetter </source>
Read MoreGrad Week 2022
A huge warm welcome to the 2022 intake of #graduates who have joined Accord Healthcare this month. Their first week was held at our site in Didcot blended inductions, sessions with senior management followed by ‘escape room’ activities and evening socials. Congratulations on your accomplishments so far and we look forward to helping you achieve your career goals. </source>
Read MoreThe Times - Future of Pharma Supplement
Our support doesn’t have to stop at chemotherapy” says Joe Dunford as part of a Q&A feature in today’s The Times discussing the Future of Pharma. #oncology #futureofpharma Click to read Click to read
Read MoreGGb Finalist
Accord Healthcare has been nominated as a finalist in seven categories in the Global Generics & Biosimilars 2022 Awards. Paul Tredwell, EVP EMENA says: “To be finalists in several categories at such a highly respected awards event is a testament to our people whose loyalty, drive and dedication to the healthcare industry go above and beyond our purpose. “We look forward to the awards evening in November and congratulate all the other finalists.” Accord Healthcare are finalists in the following categories: Company of the Year Company of the Year, EMEA Region Biosimilar Initiative of the Year Business Development of the Year Value Added Medicine Initiative of the Year Corporate Social Responsibility (CSR) Initiative of the Year Regulatory Achievement of the Year
Read MoreInnovations in Oncology
Accord Healthcare’s Executive Vice President Paul Tredwell sat down with Mark Nicholls to discuss how important it is that the pharmaceutical industry listens to patients to best tailor innovation to their needs. Paul outlines Accord’s expertise and ongoing commitment to oncology and some of the exciting plans underway in the UK, always driven by the Accord's ambition to ‘make it better’. See his interview in the latest edition of Innovations in Oncology issued in today’s The Guardian newspaper. https://www.healthawareness.</wbr>co.uk/oncology/the-</wbr>pharmaceutical-industry-has-a-</wbr>pivotal-role-in-cancer-care/?</wbr>utm_source=ACCORD-distro&utm_</wbr>medium=client #oncology #innovation #innovationsinoncology2022 #patients #pharmaceuticals #makeitbetter
Read MoreDepartment of International Trade and Health and Invest Newcastle Visit Accord’s Fawdon Site
We were pleased to welcome John Lownds of the Life Sciences and Chemical Directorate, Department of International Trade and Becky Crow, Health and Life Science Sector Lead at Invest Newcastle) to our Fawdon site last week. During the visit and factory tour, we were able to demonstrate the tremendous growth in capability and capacity already achieved on site but also the significant potential for future growth sustaining and developing sustainable long term employment within the North East Lifesciences sector. Jason Barclay, Associate VP Operations, Site Head Fawdon says of the visit: “Both John and Becky were impressed with our people and the facility and also the range of product technologies we are manufacturing and supplying from here in Fawdon. “Looking forward we are planning to work with both national and local government and agencies to help us on our journey. We have already made contact through Invest Newcastle to find ways to promote our employment offering (including Graduates and Apprentices) across the region.” #FromFawdon.For Patients Everywhere Pictured – Jason Barclay, John Lownds, Becky Crow and Ajay Varshney
Read MoreAccord Healthcare featured in The Guardian
Accord Healthcare’s Joseph Dunford and Simon Cheesman are featured in today’s Men’s Health supplement of The Guardian newspaper talking about patient priorities in prostate cancer care. Find out more here https://bit.ly/3QvGUiy and https://bit.ly/3RMWSpu and in today’s Guardian (22/09/2022)
Read MoreScience Jobs
We employ over 560 #scientists across the world to bring more #medicines to people who need them. It's our mission to make sure that everyone has access to the best possible treatments. And we're always looking for talented people to join our team https://www.linkedin.com/company/accord-healthcare/jobs
Read MoreIHP Visit Fawdon
It was a pleasure to welcome our corporate charity partner @IHP to our site at Fawdon recently. Representatives from International Health Partners highlighted the importance of our partnership, some of the positive case studies our donations have made an impact on and discussed how Accord’s donations make a difference to war torn and disaster struck countries such as Ukraine, Sudan, and many others who rely on essential medicines being donated. In addition to our people hearing from IHP, representatives from the NGO were also shown around our impressive facilities at Fawdon to gain a better understanding of the manufacturing, packing and logistical elements of our pharmaceutical organisation. Thank you for visiting Fawdon!
Read MoreSupporting IHP to Make it Better for those in Ukraine and beyond
Over the last six months, our commitment to support IHP our corporate charity partner to provide access to medicines across war torn and disaster struck countries has increased. As one of their main donors, here is a little sneak peek at what we have contributed to and IHP have delivered so far:
Read MoreAccord Germany Turns 10
A decade of dedication from our teams in Munich and beyond to achieve this milestone of delivering medicines to patients across Germany. Thank you to everyone involved in Germany’s journey. Danke schön!
Read MoreAsk Accord - Peter Kelly
We kick off a new series of 'Ask Accord' in Chemist+Druggist answering burning questions from pharmacists about the generic and biosimilar medicine industry. This first article answers the age-old question "why do generic medicine prices sometimes spike?" Peter Kelly, Managing Director at Accord has an answer. https://bit.ly/3vqT43I</wbr> #pharmacists
Read MoreBREAKING NEWS – New Partnership for Oncology Franchise
Prostate cancer is now one of the most commonly diagnosed cancers in the UK, with over 400,000 men living with #prostate cancer in the UK. Today, via a new in-license partnership that enables us to distribute a new treatment option for men living with hormone-sensitive advanced prostate cancer, we continue to build on our leadership position in #oncology whilst underpinning our commitment to supporting access to medicines for people with #cancer. We want to say thank you to our talented team that played such a large part in this milestone. Because today, our team really did make it better at Accord.
Read MoreEmployee Spotlight
Today we meet our new Associate Vice President for Operations, Fawdon, Jason Barclay and hear what attracted him to Accord. “Accord is a fast growing organisation and that for me is an attractive proposition at a personal professional level, but also as a deeply passionate and committed adoptive Northumbrian. Accord is a big employer in the region, bringing not just jobs but STEM opportunities to a wide audience and that for me was key to my next role. “Just a week into the organisation and the role and it is clear that everyone here in Fawdon is dedicated to the ongoing success of the site and there is a real sense of pride and passion to continually grow what we have to offer. “I will be spending the next few weeks engaging with the teams here in Fawdon and further afield to understand our customer base in more detail and engage with wider stakeholders. “There has been excellent investment into the site and its facilities, but it is now time to take that further. I am looking forward to delivering a long term, sustainable success story here in the North East and I know the team here are too.” If you want to join the team and be part of something, we have several vacancies.
Read MoreAccord Linkedin
We are thrilled to announce two remarkable victories at the PM Society’s 38th Annual Awards!
Accord Healthcare has been honoured with the Bronze Prize in the ‘External Communications Campaign for a Pharma or Healthcare Organisation’ category for its ‘Wish You Were Here Still’ campaign, launched in observance of International Overdose Awareness Day.
In collaboration with Swordfish Advertising, this campaign remembered those we've lost to overdose, shining a compassionate light on the sorrow of those grieving. Additionally, it was a finalist in the ‘Internal Communications’ award category.
We are also proud to secure the Silver Award in the ‘Product Brand Campaign’ category for the ‘These Are The Bones’ campaign, created with woolleypau.
The PM Society, established over forty years ago, continues to support and spotlight the best in creative communications within our industry. Their annual awards are a platform for acknowledging the innovative work supporting healthcare narratives.
A heartfelt congratulations to the teams at Accord and to our agency partners for their involvement in these campaigns. Your hard work, creativity, and passion for making a difference are what make us stand proud.
